Singapore’s Central Provident Fund $(CPF)$ system is a great way to save consistently and grow your retirement funds.

The good news is that the CPF Ordinary Account (OA) offers you the option to invest your CPF monies to enjoy even better returns through the CPF Investment Account (CPFIA).

You can use your CPFIA to invest in a wide range of Singapore stocks and REITs.

For such investments, the company in question must possess strong characteristics such as a robust business model, a consistent dividend track record and steady earnings growth.

Here are four reliable Singapore stocks that you can consider for your CPFIA.

Haw Par Corporation (SGX: H02)

Haw Par is a conglomerate with four key divisions – healthcare, leisure, property, and investments.

Its healthcare division owns the famous Tiger Balm brand which manufactures and distributes ointments, salves, and pain patches.

The group reported a commendable set of earnings for 2024.

Revenue rose 5.5% year on year to S$244.8 million although gross profit dipped slightly by 0.6% year on year to S$134.1 million.

Net profit came in at S$228.3 million, up 5.4% year on year.

The business also generated a positive free cash flow of S$50.3 million and received a total of S$149.1 million in dividend income, a step up from the S$136.2 million received in 2023.

A final dividend of S$0.20 was declared, unchanged from a year ago.

In addition, Haw Par also declared a special dividend of S$1 per share, taking the total dividend for 2024 to S$1.40 per share (inclusive of a S$0.20 interim dividend).

The conglomerate has a long, storied history of paying out increasing dividends and this special dividend is akin to extra icing on the cake.

Sheng Siong (SGX: OV8)

Sheng Siong is one of the largest supermarket chains in Singapore with 77 outlets across the island.

The retailer sells a wide variety of products including live, and chilled produce along with toiletries, general merchandise, and daily necessities.

Sheng Siong demonstrated steady store growth since 2020 when the pandemic broke out, with its store count increasing from 63 to 77 today.

2024 saw continued growth in the retailer’s top and bottom lines.

Revenue rose 4.5% year on year to S$1.4 billion while operating profit inched up 2.7% year on year to S$159.7 million.

Net profit increased by 2.6% year on year to S$137.5 million.

The supermarket operator’s free cash flow jumped 20.3% year on year to S$200.8 million.

Sheng Siong paid out a total dividend of S$0.064, a step up from the S$0.0625 paid for 2023.

The group intends to open at least three new stores per year and for 2024, it doubled this target by opening six new stores.

Management is waiting for the results of the tender for eight additional stores to be released which could see the retailer opening more stores this year in addition to the two that opened in the first two months of 2025.

CapitaLand Integrated Commercial Trust (SGX: C38U)

CapitaLand Integrated Commercial Trust, or CICT, is a retail and commercial REIT with a portfolio of 21 properties in Singapore, two properties in Germany, and three properties in Australia.

The REIT had assets under management (AUM) of S$26 billion as of 31 December 2024.

CICT reported a commendable performance despite the presence of headwinds such as high interest rates and persistent inflation.

For 2024, gross revenue edged up 1.7% year on year to S$1.6 billion while net property income improved by 3.4% year on year to S$1.15 billion.

Distribution per unit (DPU) crept up 1.2% year on year to S$0.1088.

Apart from a resilient financial performance, CICT also displayed solid operating metrics.

The portfolio’s committed occupancy stood at 96.7% while rental reversion came in positive at 8.8% and 11.1% for the REIT’s retail and office divisions, respectively.

The REIT has two asset enhancement initiatives (AEIs) slated for completion in the second half of this year and should see a full-year contribution from the acquisition of ION Orchard Mall.

Parkway Life REIT (SGX: C2PU)

Parkway Life REIT, or PLife REIT, is a healthcare REIT with a portfolio of 75 properties – three in Singapore, 60 in Japan, 11 in France, and one in Malaysia.

Its total AUM stood at around S$2.46 billion as of 31 December 2024.

PLife REIT reported a mixed set of earnings for 2024.

Gross revenue and NPI dipped by 1.5% and 1.8% year on year, respectively, to S$145.3 million and S$136.6 million.

However, DPU stood at S$0.1492, up 1% year on year.

The healthcare REIT maintained a moderate gearing level of 34.8% and had a very low cost of debt of just 1.48%.

The REIT has also hedged 87% of its interest rate exposure to mitigate further rises in its finance costs.

PLife REIT has an enviable of uninterrupted increases in its core DPU since its IPO back in 2007.

Close to 91% of its leases (by gross revenue) also have downside protection.

Just 2% of the REIT’s loans are due for refinancing this year.